Literature DB >> 26003956

Oki stenting for anastomotic bronchomalacia in lung transplantation.

Daniel López-Padilla1, Ricardo García-Luján2, Alicia de Pablo3, Eduardo de Miguel Poch3.   

Abstract

Anastomotic airway complications are a frequent cause of disease in lung transplantation. However, there is no consensus on the type of treatment to be performed with prosthetic devices. While some recent gadgets such as the Oki stent have been proposed for main right bronchus stenosis, there are no reports of stenting using this prosthesis in cases where the main complication is malacia rather than stenosis. We present 2 patients diagnosed with main right bronchus bronchomalacia, also involving bronchius intermedius. After several attempts to bypass the anastomosis employing different types of stent, including a T-tube Montgomery device, normal sputum drainage was not possible. Oki stenting was performed without complications, with a remarkable reduction in endoscopic procedures as well as important functional improvement. For both stenosis and bronchomalacia in lung transplantation, we propose Oki stenting as the first choice of treatment.
© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Bronchomalacia; Lung transplantation; Stents

Mesh:

Year:  2015        PMID: 26003956     DOI: 10.1093/ejcts/ezv200

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Metallic small y stent placement at primary right carina for bronchial disease.

Authors:  Yonghua Bi; Jindong Li; Zepeng Yu; Jianzhuang Ren; Gang Wu; Xinwei Han
Journal:  BMC Pulm Med       Date:  2018-11-29       Impact factor: 3.317

2.  Clinical outcomes of metallic Y-shaped covered stents for bronchopleural fistula around upper carina after lobectomy.

Authors:  Yonghua Bi; Xiaoyan Zhu; Zepeng Yu; Gang Wu; Xinwei Han; Jianzhuang Ren
Journal:  BMC Pulm Med       Date:  2019-11-05       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.